Simone Amicizia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Simone Amicizia has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Berni
Division of Cardiology, Sant’Andrea Hospital, 00189 Rome, Italy; Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy
1 shared publication - Antonella Tommasino
Division of Cardiology, Sant’Andrea Hospital, 00189 Rome, Italy
1 shared publication - Camilla Ciani
Division of Cardiac Surgery, Sant’Andrea Hospital, 00189 Rome, Italy; Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy
1 shared publication - Emanuele Barbato
Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00185 Roma, Italy
1 shared publication - Emiliano Marco Navarra
Department of Cardiac Surgery, San Carlo di Nancy Hospital—GVM , Roma
1 shared publication - Federico Dell'AQuila
Division of Cardiology, Sant’Andrea Hospital, 00189 Rome, Italy; Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy
1 shared publication
Latest Publications
- 6 June 2024
- Published by IMR Press in The Heart Surgery Forum
- Vol. 27 (6) , E689-E700
Hybrid Coronary Revascularization in Multivessel Disease: The Ideal Strategy for Challenging Scenarios
The treatment of coronary artery disease (CAD) has considerably evolved over the last three decades thanks to innovations in percutaneous and surgical revascularization techniques. The demographic shift towards an aging population with complex coronary anatomy and multiple comorbidities necessitates a personalized approach. A primary challenge for Heart Teams is to integrate new strategies into their decision-making process. Hybrid coronary revascularization (HCR) combines the long-term benefits of coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) to treat complex coronary artery disease. Selection of the ideal candidate for HCR requires careful evaluation of anatomic challenges and risk profiles. Although recent evidence demonstrates the safety and efficacy of HCR and makes it a viable alternative to conventional methods, further large-scale randomized controlled trials (RCTs) are needed to establish its role in routine practice. In this manuscript, we have provided an overview of the major advances in both percutaneous and surgical techniques. In addition, we have addressed the innovative implications of robotic-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB) and described the surgical procedure and postoperative care in detail. Finally, we have outlined the key principles that guide our clinical practice in selecting the appropriate approach for hybrid coronary revascularization.
- 6 June 2024
- Published by IMR Press in The Heart Surgery Forum
- Vol. 27 (6) , E689-E700
Hybrid Coronary Revascularization in Multivessel Disease: The Ideal Strategy for Challenging Scenarios
The treatment of coronary artery disease (CAD) has considerably evolved over the last three decades thanks to innovations in percutaneous and surgical revascularization techniques. The demographic shift towards an aging population with complex coronary anatomy and multiple comorbidities necessitates a personalized approach. A primary challenge for Heart Teams is to integrate new strategies into their decision-making process. Hybrid coronary revascularization (HCR) combines the long-term benefits of coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) to treat complex coronary artery disease. Selection of the ideal candidate for HCR requires careful evaluation of anatomic challenges and risk profiles. Although recent evidence demonstrates the safety and efficacy of HCR and makes it a viable alternative to conventional methods, further large-scale randomized controlled trials (RCTs) are needed to establish its role in routine practice. In this manuscript, we have provided an overview of the major advances in both percutaneous and surgical techniques. In addition, we have addressed the innovative implications of robotic-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB) and described the surgical procedure and postoperative care in detail. Finally, we have outlined the key principles that guide our clinical practice in selecting the appropriate approach for hybrid coronary revascularization.